Predictive value of the HALP score for pre-eclampsia with severe features

dc.authorid0000-0003-1496-3732
dc.authorid0000-0003-1557-5774
dc.contributor.authorSoykan Sert, Zekiye
dc.contributor.authorBertizlioğlu, Mete
dc.date.accessioned2024-07-18T06:36:52Z
dc.date.available2024-07-18T06:36:52Z
dc.date.issued2024
dc.departmentTıp Fakültesi
dc.description.abstractPredictive tests are needed to ensure the development and subsequent follow-up of pre-eclampsia, which is responsible for significant rates of morbidity and mortality during pregnancy. This study aimed to evaluate the predictive value of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score for the severity of preeclampsia. Methods: We retrospectively analyzed the data of women diagnosed with pre-eclampsia at our clinic from January 2019 to January 2023. The control group consisted of normotensive, healthy pregnant women. Women diagnosed with preeclampsia were further evaluated in two groups: those with severe features and those without severe features. The clinical and demographic data of the cases were evaluated. The HALP score was calculated using the first trimester blood parameters of the cases and compared between groups. Results: The study included 229 patients with preeclampsia and 142 normotensive healthy controls. Of the patients with preeclampsia, 104 (28.1%) had severe features of the disease. The HALP score was significantly higher in the preeclampsia group with severe features than in the control group (6.18 ± 2.66 vs. 3.75 ± 1.86; p = 0.006). In multivariate logistic regression analysis, the HALP score (odds ratio: 2.02, 95% confidence interval: 1.10–3.32, p = 0.017) was found to be an independent indicator for preeclampsia with severe features. A HALP score of > 4.61 predicted the development of preeclampsia with severe features with a sensitivity of 74.5% and a specificity of 81.3%. Conclusion: We found a significant correlation between the HALP score and preeclampsia with severe features. The HALP score may be useful in predicting the severity of preeclampsia.
dc.identifier.doi10.1080/00325481.2024.2359892
dc.identifier.endpage473en_US
dc.identifier.issn0032-5481
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ1
dc.identifier.startpage468en_US
dc.identifier.urihttps:/dx.doi.org/10.1080/00325481.2024.2359892
dc.identifier.urihttps://hdl.handle.net/20.500.12451/12147
dc.identifier.volume136en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofPostgraduate Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectFirst Trimester
dc.subjectHALP Score
dc.subjectPredictive Value
dc.subjectPreeclampsia
dc.subjectSevere Features
dc.titlePredictive value of the HALP score for pre-eclampsia with severe features
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
soykan sert-zekiye-2024.pdf
Boyut:
719.43 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: